Finance

Lists
Why is ENTX down ३.४२%?
Dive Deeper
ENTX:NASDAQ
Entera Bio Ltd
US$ ३.११
-३.४२%
(-०.११) 1D
नोभेम्बर १३, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
US$ ३.२२
High
US$ ३.२६
Low
US$ ३.०८
Mkt. cap
५४.१६ करोड
Avg. vol.
४.९९ लाख
Volume
१.५५ लाख
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३९
Beta
१.४८
Shares outstanding
१७.४१ करोड
No. of employees
२७
Open
US$ ३.२२
High
US$ ३.२६
Low
US$ ३.०८
Mkt. cap
५४.१६ करोड
Avg. vol.
४.९९ लाख
Volume
१.५५ लाख
52-wk high
US$ ४.२०
52-wk low
US$ ०.९१
EPS
-US$ ०.३९
Beta
१.४८
Shares outstanding
१७.४१ करोड
No. of employees
२७
News stories
From web sources and news partners
Foreign Policy Journal
Foreign Policy Journal
·
४३ मिनेट पहिले
BigBear.ai (NASDAQ: BBAI) Swings To A $91.9 Million Quarterly Loss Even As Federal AI Contracts Surpass $225 Million
Bloomberg.com
Bloomberg.com
·
८ घण्टा पहिले
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
AP News
AP News
·
२३ घण्टा पहिले
Microsoft outage shows the risks of relying on a single technology provider for essential services
Investor's Business Daily
Investor's Business Daily
·
३ घण्टा पहिले
New Rally Shaky, But Many Stocks Set Up. Nvidia, Anthropic Ahead.
About Entera Bio Ltd
CEO-
Employees२७
Founded२००९
Headquarters-
SectorHealth Care
Industry-
Websiteenterabio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current US$ ३.११
US$ ११.०० (+२५३.७०%)
Average
US$ १०.०० (+२२१.५४%)
Lowest
US$ ९.०० (+१८९.३९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Maintained
US$ ११.००
+२५३.७%
11/09/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
US$ १०.००
+२२१.५%
10/14/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
US$ ९.००
+१८९.४%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
US$ ९.००
+१८९.४%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१७.१८ लाख
२२.५१ लाख
३२.०१ लाख
४९.२५ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१३.२४ लाख
१२.८८ लाख
१३.६२ लाख
२३.४० लाख
Operating expense
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
७२.६५ लाख
Total operating expenses
३०.४२ लाख
३५.३९ लाख
४५.६३ लाख
७२.६५ लाख
Operating income
-३०.४२ लाख
-३५.३९ लाख
-४५.६३ लाख
-७२.६५ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
-१.५६ करोड
EBT excluding unusual items
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
-१.५६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३०.१६ लाख
-३५.०५ लाख
-७३.१२ लाख
-१.५६ करोड
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
२६.०० हजार
३४.०० हजार
-
-
Interest expense
-
-
-२७.४९ लाख
-८३.३२ लाख
Net interest expenses
२६.०० हजार
३४.०० हजार
-२७.४९ लाख
-८३.३२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-३०.३५ लाख
-३५.३२ लाख
-४५.५४ लाख
-७२.५६ लाख
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू